Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
Recruiting now
Conditions studied: Rectal Cancer, Quality of Life, Radiation Therapy, Chemoradiation
In brief
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional Outcome, oncological outcome and toxicity in patients treated with neoadjuvant short term radiation or long-term chemoradiation followed by surgery
Key facts
- Study ID
- NCT03731130
- Run by
- Ludwig-Maximilians - University of Munich
- People needed
- 100
- Starts
- 2018-10-05
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2018-11-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- histologically proven rectal Cancer without distant metastases
- indication for neoadjuvant Radiation or chemoradiation therapy according to multidiciplinary Evaluation
- age >=18 years
- written informed consent
- ability to answer the standardized questionaires according to the treating physician
You may not qualify if…
- age < 18 years
- prior systemic therapy with regard to rectal Cancer
- distant metastasis
- second malignancy
Where it is running
- Department of Radiation Oncology, University Hospital, LMU Munich — Munich, Bavaria, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.